Thomas Theriault
Fondatore presso Bullet Biotechnology, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Julian Baker | M | 57 | 23 anni | |
| Diego Fonstad | M | - |
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | 13 anni |
| James R. Swartz | M | - |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | 13 anni |
| Samuel Saks | M | 69 |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | 12 anni |
| Paula Swain | F | 66 | 22 anni | |
| Hari Kumar | M | 69 |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | - |
| Keith Mikkelson | M | - | 22 anni | |
| Julie Vose | F | - |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Paul Friedman | M | 81 | 20 anni | |
| William Quinn | M | 53 |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | 6 anni |
| Laurent Chardonnet | M | 59 | - | |
| Andrew Combs | M | 58 | 16 anni | |
| Laura Randall Woodhead | F | 56 | 6 anni | |
| Richard Levy | M | 66 | 13 anni | |
| Reid Huber | M | 52 | 16 anni | |
| Steve Friedman | M | 78 | - | |
| Barry Michael Ariko | M | 78 | 14 anni | |
| Paul Brooke | M | 77 | 19 anni | |
| David Hastings | M | 62 | 11 anni | |
| Robert Stein | M | 73 | 2 anni | |
| Elias Bendekgey | M | 66 | 6 anni | |
| Richard de Schutter | M | 83 | 12 anni | |
| Paul Trower | M | 54 | 18 anni | |
| Krishna Vaddi | M | 58 | 13 anni | |
| Patricia A. Schreck | F | 70 | 8 anni | |
| Kirk Trisler | M | 64 | 3 anni | |
| Richard D. Goold | M | 64 | 9 anni | |
| Peggy Scherle | M | 62 | 16 anni | |
| Kim Solomon | M | - | 9 anni | |
| Wenqing Yao | M | 61 | - | |
| Phillip Liu | M | - | 17 anni | |
| Mark Oki | M | 55 | 3 anni | |
| Samuel T. LaBrie | M | - | 5 anni | |
| H. David Miller | M | 77 | 3 anni | |
| Ronald L. Goode | M | 79 | - | |
| Steven Chamow | M | 70 | 2 anni | |
| Tod M. Klingler | M | 59 | - | |
| Thomas DeZAo | M | 66 | 6 anni | |
| John Apeler Keller | M | 60 | 5 anni | |
| Bonnie Charpentier | M | 72 | 5 anni | |
| Stanford C. Finney | M | 75 | 5 anni | |
| Brian W. Metcalf | M | 78 | 9 anni | |
| John M. Vuko | M | 73 | 4 anni | |
| Michael D. Lack | M | 72 | 3 anni | |
| Mary Ellen Rybak | M | 74 | 2 anni | |
| Michael J. Buckley | M | 73 | 3 anni | |
| Gregory Overholtzer | M | 67 | 2 anni | |
| Claude Miller | M | 73 | 4 anni | |
| James P. Merryweather | M | - | 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 49 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Thomas Theriault
- Contatti personali
